Medicine
Tyvaso DPI kit
Tyvaso DPI kit is a prescription medicine containing Treprostinil, marketed by United Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Tyvaso DPI Presentation Refrigerated storage 2°C to 8°C (36°F to 46°F) Room…
Key facts
- Active ingredient (INN)
- Treprostinil
- Brand
- Tyvaso DPI
- Dosage form
- Kit
- Packs
- 1 kit and 5 more
- Marketing authorisation holder
- United Therapeutics
- Manufacturer
- United Therapeutics
- Origin register
- US FDA, United States
- Storage
- Tyvaso DPI Presentation Refrigerated storage 2°C to 8°C (36°F to 46°F) Room temperature storage 20°C to 25°C (68°F to 77°F), excursions permitted 15°C to 30°C (59°F to 86°F) Sealed (Unopened) Blister Cards or Strips May be stored until the expiration date printed on the blisters.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC21 Treprostinil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 May 2022
- Identifiers
- RxCUI 2602751, 2602754, 2602756 +7DailyMed set ID ddc3d400-bcb3-4b09-aae2-0768b10a5b0fNDC 66302-630, 66302-670, 66302-640 +5Application NDA214324
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-610-02 | United Therapeutics | 23 May 2022 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-620-03 | United Therapeutics | 23 May 2022 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-630-03 | United Therapeutics | 27 June 2023 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-640-03 | United Therapeutics | 27 June 2023 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-650-03 | United Therapeutics | 27 June 2023 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-660-03 | United Therapeutics | 7 November 2025 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-670-03 | United Therapeutics | 7 November 2025 |
| 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack | 66302-720-04 | United Therapeutics | 23 May 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Treprostinil kit.
Other strengths and forms of Treprostinil
Clinical summary
Treprostinil is a prostacycline vasodilator indicated for treatment of pulmonary arterial hypertension (PAH, WHO Group 1) to diminish symptoms associated with exercise, among other approved uses. MedsAcross supplies Treprostinil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TreprostinilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Remodulin prescribing information (United Therapeutics) · U.S. National Library of Medicine, DailyMed
- Trepulmix: European public assessment report (EPAR) · European Medicines Agency
Need Tyvaso DPI kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.